Regulation of CXCR4 gene expression in breast cancer cells under diverse stress conditions

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 2253-2259

  Andreou, Kleopatra ^a   Rajendran, Ramkumar ^a   Krstic Demonacos, Marija ^a   Demonacos, Constantinos ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Breast cancer; Hypoxia; Inflammation; Transcription

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DEFEROXAMINE; ETOPOSIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; SIRTUIN 1; STEROID RECEPTOR COACTIVATOR 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; ETOPOSIDE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-10; MCF-7 CELLS; NUCLEAR RECEPTOR COACTIVATOR 1; PROMOTER REGIONS, GENETIC; RECEPTORS, CXCR4; RNA, MESSENGER; SIRTUIN 1; STRESS, PHYSIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84869748129     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1643     Document Type: Article

References (41)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001. (Pubitemid 32173595)
2. de Visser KE, Eichten A and Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37, 2006. (Pubitemid 43053650)
3. Allavena P, Garlanda C, Borrello MG, Sica A and Mantovani A: Pathways connecting inflammation and cancer. Curr Opin Genet Dev 18: 3-10, 2008. (Pubitemid 351694444)
4. Lin WW and Karin M: A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117: 1175-1183, 2007.
5. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
6. Shiao SL, Ganesan AP, Rugo HS and Coussens LM: Immune microenvironments in solid tumours: new targets for therapy. Genes Dev 25: 2559-2572, 2011.
7. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
8. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK and Sethi G: Inflammation and cancer: how hot is the link? Biochem Pharmacol 72: 1605-1621, 2006. (Pubitemid 44666739)
9. Balkwill F: TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25: 409-416, 2006.
10. Mocellin S, Marincola FM and Young HA: Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 78: 1043-1051, 2005. (Pubitemid 41572467)
11. Ali S and Lazennec G: Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev 26: 401-420, 2007. (Pubitemid 350115103)
12. Balkwill F: Chemokine biology in cancer. Semin Immunol 15: 49-55, 2003.
13. Allavena P, Germano G, Marchesi F and Mantovani A: Chemokines in cancer-related inflammation. Exp Cell Res 317: 664-673, 2011.
14. Luker KE and Luker GD: Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: 30-41, 2006. (Pubitemid 44183757)
15. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
16. Uygur B and Wu WS: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer 10: 139, 2011.
17. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
18. Denko NC, Fontana LA, Hudson KM, et al: Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22: 5907-5914, 2003. (Pubitemid 37176711)
19. Schioppa T, Uranchimeg B, Saccani A, et al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198: 1391-1402, 2003. (Pubitemid 37392484)
20. Mehta SA, Christopherson KW, Bhat-Nakshatri P, et al: Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene 26: 3329-3337, 2007. (Pubitemid 46788879)
21. Webster GA and Perkins ND: Transcriptional cross-talk between NF-kappaB and p53. Mol Cell Biol 19: 3485-3495, 1999.
22. Xenaki G, Ontikatze T, Rajendran R, et al: PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 27: 5785-5796, 2008.
23. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T and Neckers L: p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273: 11995-11998, 1998. (Pubitemid 28240554)
24. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV and Neckers LM: Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408, 1998.
25. Lee SK, Kim HJ, Kim JW and Lee JW: Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol Endocrinol 13: 1924-1933, 1999. (Pubitemid 30645265)
26. Ruas JL, Poellinger L and Pereira T: Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci 118: 301-311, 2005. (Pubitemid 40277343)
27. Rajendran R, Garva R, Krstic-Demonacos M and Demonacos C: Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol 2011: 368276, 2011.
28. Xu J, Wu R-C and O'Malley BW: Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9: 615-630, 2009.
29. Onate SA, Tsai SY, Tsai MJ and O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357, 1995.
30. Demonacos C and La Thangue NB: Drug discovery and the p53 family. Prog Cell Cycle Res 5: 375-382, 2003.
31. Keimling M and Wiesmuller L: DNA double-strand break repair activities in mammary epithelial cells - influence of endogenous p53 variants. Carcinogenesis 30: 1260-1268, 2009.
32. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H and Poellinger L: Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol 20: 402-415, 2000. (Pubitemid 30002581)
33. Lavery DN and Bevan CL: Androgen receptor signalling in prostate cancer: the functional consequences of acetylation. J Biomed Biotechnol 2011: 862125, 2011.
34. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J and Le AD: Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4: 1465-1474, 2005. (Pubitemid 41556428)
35. Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim J-E and Park J-W: Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1α. Mol Cell 38: 864-878, 2010.
36. De Nardo D and Latz E: NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 32: 373-379, 2011.
37. Strober W and Fuss IJ: Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756-1767, 2011.
38. Mantovani A, Marchesi F, Porta C, Sica A and Allavena P: Inflammation and cancer: breast cancer as a prototype. Breast 16 (Suppl 2): S27-S33, 2007.
39. Toi M, Bicknell R and Harris AL: Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52: 275-279, 1992.
40. Murdoch C and Lewis CE: Macrophage migration and gene expression in response to tumor hypoxia. Int J Cancer 117: 701-708, 2005. (Pubitemid 41598819)
41. Hussain SP and Harris CC: Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121: 2373-2380, 2007. (Pubitemid 350022405)